This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simizu, S. Articles by Osada, H. Search for Related Content PubMed PubMed Citation Articles by Simizu, S. Articles by Osada, H.

RECK-Mediated Suppression of Tumor Cell Invasion Is Regulated by Glycosylation in Human Tumor Cell Lines

¹ Antibiotics Laboratory, Discovery Research Institute, RIKEN and ² Graduate School of Science and Engineering, Saitama University, Japan

Requests for reprints: Hiroyuki Osada, Antibiotics Laboratory, Discovery Research Institute, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. Phone: 81-48-467-9541; Fax: 81-48-462-4669; E-mail: hisyo{at}riken.jp.

RECK, a glycosylphosphatidylinositol (GPI)–anchored glycoprotein, negatively regulates matrix metalloproteinases (MMP), such as MMP-9, and inhibits tumor invasion and metastasis. The predicted amino acid sequence of human RECK includes five putative N-glycosylation sites; however, the precise biochemical role of glycosylated RECK remains unknown. In this study, we examined the link between glycosylation and the function of RECK in human tumor cell lines. RECK protein was glycosylated at Asn⁸⁶, Asn²⁰⁰, Asn²⁹⁷, and Asn³⁵² residues but not at the Asn³⁹ residue in HT1080 cells. Although the glycosylation of these asparagine sites did not play a role in the cell surface localization of RECK as a GPI-anchored protein, the glycosylation of RECK Asn²⁹⁷ residue was involved in the suppression of MMP-9 secretion and Asn³⁵² residue was necessary to inhibit MMP-2 activation. Moreover, RECK-suppressed tumor cell invasion was reversed by inhibiting glycosylation at Asn⁸⁶, Asn²⁹⁷, and Asn³⁵² residues of RECK. Thus, these findings indicate that glycosylation mediates RECK suppression of tumor cell invasion by multiple mechanisms such as suppressing MMP-9 secretion and inhibiting MMP-2 activation.

This article has been cited by other articles:

				S. Takagi, S. Simizu, and H. Osada RECK Negatively Regulates Matrix Metalloproteinase-9 Transcription Cancer Res., February 15, 2009; 69(4): 1502 - 1508. [Abstract] [Full Text] [PDF]

				A. Omura, T. Matsuzaki, K. Mio, T. Ogura, M. Yamamoto, A. Fujita, K. Okawa, H. Kitayama, C. Takahashi, C. Sato, et al. RECK Forms Cowbell-shaped Dimers and Inhibits Matrix Metalloproteinase-catalyzed Cleavage of Fibronectin J. Biol. Chem., February 6, 2009; 284(6): 3461 - 3469. [Abstract] [Full Text] [PDF]

				S.-J. Hu, G. Ren, J.-L. Liu, Z.-A. Zhao, Y.-S. Yu, R.-W. Su, X.-H. Ma, H. Ni, W. Lei, and Z.-M. Yang MicroRNA Expression and Regulation in Mouse Uterus during Embryo Implantation J. Biol. Chem., August 22, 2008; 283(34): 23473 - 23484. [Abstract] [Full Text] [PDF]

				S. Simizu, T. Suzuki, M. Muroi, N. S. Lai, S. Takagi, N. Dohmae, and H. Osada Involvement of Disulfide Bond Formation in the Activation of Heparanase Cancer Res., August 15, 2007; 67(16): 7841 - 7849. [Abstract] [Full Text] [PDF]